Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pediatric Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
100%
Residual Disease
100%
Acute Lymphoblastic Leukemia
40%
Molecular Genetics
30%
Risk-adapted
30%
Optimal Methodology
20%
Disease Level
20%
Clinical Trials
10%
T Cell Immunoglobulin
10%
Treatment Intensification
10%
Disease Detection
10%
Molecular Genetic Technologies
10%
TaqMan Technology
10%
Genetic Data
10%
T Cell Receptor
10%
Clinical Parameters
10%
Immunoglobulin Heavy Chain Gene Rearrangement
10%
Quantitative PCR
10%
Laboratory Parameters
10%
Flow Cytometry
10%
Therapeutic Development
10%
Newly Diagnosed
10%
Group Interaction
10%
Prognostic Utility
10%
Early Treatment
10%
Genetic Sequence
10%
Laboratory Data
10%
Treatment Course
10%
Specific Aims
10%
Sequence Detector
10%
Genetic Analyzer
10%
Resistant Disease
10%
Treatment Trials
10%
Pediatric Oncology
10%
Risk for Relapse
10%
Preclinical Data
10%
Leukemia Patients
10%
Biochemistry, Genetics and Molecular Biology
Molecular Genetics
100%
Pediatrics
100%
Genetics
50%
T Cell Receptor
25%
Intravenous Immunoglobulin
25%
Group Dynamics
25%
Quantitative Technique
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Flow Cytometry
25%
TaqMan
25%
Clinical Trial
25%
Heavy Chain
25%
Cytogenetics
25%
Genetic Technology
25%
Medicine and Dentistry
Minimal Residual Disease
100%
Pediatrics
100%
Acute Lymphoblastic Leukemia
100%
Genetics
50%
Diseases
16%
Flow Cytometry
8%
Immunoglobulin Heavy Chain
8%
T Lymphocyte Receptor
8%
Group Dynamics
8%
Clinical Trial
8%
Childhood Cancer
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Disease Assessment
8%
Sensitivity and Specificity
8%